Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 229-230 , July 2007

Will Innovations in Dialysis Improve Dialysis Care?

  • Alan S. Kliger, MD

      Affiliations

    • Hospital of St. Raphael and Yale University, New Haven, CT
    • ,
  • Mary Gellens, MD

      Affiliations

    • Baxter Healthcare, McGraw Park, IL

References 

  1. U.S. Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal disease in the United States, National Institutes of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  2. Lowrie EG, Laird NM, Parker TF, et al. Effect of the hemodialysis prescription of patient morbidity (Report from the National Cooperative Dialysis Study). N Engl J Med. 1981;305:1176–1181
  3. Eknoyan G, Beck GJ, Cheung AK, et al. Hemodialysis (HEMO) Study Group Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–2019
  4. Paniagua R, Amato D, Vonesh E, et al. Mexican Nephrology Collaborative Study Group Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADAMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13:1307–1320
  5. Charra B, Calemard E, Cuche M, et al. Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron. 1983;33:96–99
  6. Troidle L, Hotchkiss M, Finkelstein F. A thrice weekly in-center nocturnal hemodialysis program. Adv Chronic Kidney Dis. 2007;14:244–248
  7. Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int. 2006;69:1222–1228
  8. Rocco MV. More frequent hemodialysis: Back to the future?. Adv Chronic Kidney Dis. 2007;14:e1–e9
  9. Kliger AS Frequent Hemodialysis Network Study Group. High-frequency hemodialysis: Rationale for randomized clinical trials. Clin J Am Soc Nephrol. 2007;2:390–392
  10. Arantharaman P, Moss AH. Should the Medicare ESRD program pay for daily dialysis. Adv Chronic Kidney Dis. 2007;14:290–296
  11. Decker BS, Mueller BA, Sowinski KM. Drug dosing considerations in alternative hemodialysis. Adv Chronic Kidney Dis. 2007;14:e17–e26
  12. Wystrychowski G, Levin NW. Dry weight: Sine qua non of adequate dialysis. Adv Chronic Kidney Dis. 2007;14:e10–e16
  13. Ouseph R, Ward RA. Ultrapure dialysate for home hemodialysis. Adv Chronic Kidney Dis. 2007;14:256–262
  14. Ronco C, Cruz D. Hemodiafiltration history, technology, and clinical results. Adv Chronic Kidney Dis. 2007;14:231–243
  15. Hamlett L, Haragsim L. Quotidian hemodialysis and inflammation associated with chronic kidney disease. Adv Chronic Kidney Dis. 2007;14:e35–e42
  16. Moran J. The resurgence of home dialysis therapies. Adv Chronic Kidney Dis. 2007;14:284–289
  17. Pollock CA, Cooper BA, Harris DC. Early start peritoneal dialysis. Adv Chronic Kidney Dis. 2007;14:e27–e34
  18. Povlsen JV, Ivarsen P. Assisted peritoneal dialysis. Adv Chronic Kidney Dis. 2007;14:279–283
  19. Holmes CJ. Glucotoxicity in peritoneal dialysis—solutions for the solution!. Adv Chronic Kidney Dis. 2007;14:269–278
  20. Mujais S, Story K. Improving cycler prescriptions in peritoneal dialysis through informatic profiling. Adv Chronic Kidney Dis. 2007;14:263–268
  21. Rastogi A, Nissenson AR. The future of renal replacement therapy. Adv Chronic Kidney Dis. 2007;14:249–255

PII: S1548-5595(07)00054-7

doi: 10.1053/j.ackd.2007.03.010

Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 229-230 , July 2007

Article Tools